i4i PDA NICE Early Use
Supports innovators with medical devices, in vitro diagnostics, or NICE-classified digital health technology through NIHR i4i PDA Early Use opportunities.
The i4i PDA NICE Early Use — April 2026 is a themed commissioned sub-call running in parallel with the main i4i Product Development Awards April 2026 cycle under NIHR's Invention for Innovation programme. It carries the reference ID 2026/400 and specifically targets innovations positioned for evaluation via NICE's early-use pathways — regulatory mechanisms through which NICE can recommend health t…
Innovations positioned for evaluation via NICE early-use pathways. Must be classified as medical device, IVD, or NICE digital health technology.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Guides for this application
All guides →Grant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
Write proposalGrant Concept Note Example: Pre-Proposal Structure for Startups
See a practical grant concept note example, with a worked deeptech pre-proposal, section map, invite-to-full logic, and reviewer checks.
DocumentsLetter of Support for Grant Applications: Template and Examples
Learn how to write and request a letter of support for a grant, with template structure, examples, reviewer logic, and common mistakes.
Find grantsGovernment Grants for Startups: What Deeptech Founders Should Know
A practical guide to government grants for startups, including Grants.gov, SBIR/STTR, state programs, eligibility, fit, timelines, and when to apply.
More from NIHR
All grants from this funder →Reconstruction surgery for FGM/C survivors
🇬🇧NIHR · United Kingdom
Funds a UK trial on the benefits and harms of reconstructive surgery for FGM/C survivors.
Early surgical intervention compared to standard care in neonates with symptoms of necrotising enterocolitis (NEC)
🇬🇧NIHR · United Kingdom
Funds a UK trial testing early surgery against standard monitoring for neonates with NEC.
Interventions for school-aged children with a developmental stammer
🇬🇧NIHR · United Kingdom
Funds a UK trial of therapy for school-aged children who stammer and want treatment.
Reducing central line-associated bloodstream infections in neonates
🇬🇧NIHR · United Kingdom
Funds a UK trial comparing interventions to cut bloodstream infections from neonatal lines.
EME Programme researcher-led
🇬🇧NIHR · United Kingdom
Funds efficacy and mechanism studies on NHS interventions, up to about £500k for mechanistic work.
Air Quality in Indoor Public Spaces, Workplace Settings and Transport Microenvironments
🇬🇧NIHR · United Kingdom
Funds UK research on health impacts of indoor and transport air-quality interventions.
Similar grants
Browse the directory →US-Ireland R&D Partnership
🇮🇪Research Ireland · Ireland
Funds tri jurisdiction collaboration between the United States, Republic of Ireland, and Northern Ireland through a science and technology partnership.
UKRI International Science Partnerships Fund
🇬🇧UKRI · United Kingdom
Supports United Kingdom researchers connecting globally through partnerships in planet, health, technology, and talent priorities via UKRI International Science Partnerships Fund.
Eureka Network Projects — Permanent
🇪🇺EUREKA · Global / Multinational
Offers open access collaboration through Eureka Network Projects so small enterprises can join international innovation groups.
Innowwide — Next
🇪🇺EUREKA · Global / Multinational
Offers market-feasibility support for small companies exploring non-European markets through Europe-wide innovation networks.
Eurostars Call 11 (UK)
🇬🇧Innovate UK · United Kingdom
Funds United Kingdom firms in multinational innovation consortia for export readiness.
EIC Pathfinder Challenges
🇪🇺EIC · European Union
Funds European consortia developing breakthrough solutions across AI, climate, energy, materials, medical, and quantum fields.